These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2184511)

  • 1. Overview of studies of fluconazole in oropharyngeal candidiasis.
    Hay RJ
    Rev Infect Dis; 1990; 12 Suppl 3():S334-7. PubMed ID: 2184511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
    AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.
    Meunier F; Aoun M; Gerard M
    Rev Infect Dis; 1990; 12 Suppl 3():S364-8. PubMed ID: 2184513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
    Jandourek A; Vaishampayan JK; Vazquez JA
    AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
    Lim SG; Lee CA; Hales M; O'Doherty M; Winter M; Kernoff PB
    Aliment Pharmacol Ther; 1991 Apr; 5(2):199-205. PubMed ID: 1888820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.
    Leen CL; Dunbar EM; Ellis ME; Mandal BK
    J Infect; 1990 Jul; 21(1):55-60. PubMed ID: 2200826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected].
    Marchisio P; Principi N
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):338-40. PubMed ID: 8070442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
    Skiest DJ; Vazquez JA; Anstead GM; Graybill JR; Reynes J; Ward D; Hare R; Boparai N; Isaacs R
    Clin Infect Dis; 2007 Feb; 44(4):607-14. PubMed ID: 17243069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triazole therapy for mucocutaneous candidiasis in HIV-infected patients.
    Thomas CJ
    J Assoc Nurses AIDS Care; 1998; 9(5):36-44. PubMed ID: 9742479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
    Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
    Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study.
    Vazquez JA; Hidalgo JA; De Bono S
    HIV Clin Trials; 2000; 1(3):23-9. PubMed ID: 11590502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    Hernández-Sampelayo T
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
    Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
    Corzo Delgado JE; Lozano de León F; Aretio Najarro R; Martín Mazuelos E
    Med Clin (Barc); 1994 Nov; 103(16):639. PubMed ID: 7996928
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
    De Wit S; O'Doherty E; De Vroey C; Clumeck N
    J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis.
    Vandercam B; Gibbs D; Valtonen M; Jäger H; Armignacco O
    J Int Med Res; 1998; 26(4):209-18. PubMed ID: 9818788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
    Taillandier J; Esnault Y; Alemanni M
    Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicenter study of fluconazole in the treatment of oropharyngeal candidiasis in immunodepressed patients].
    Muñoz P; Moreno S; Garau X; López Bernaldo de Quirós JC; Berenguer J; More J; Bouza E
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):560-4. PubMed ID: 2099857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.